Global experts discover new genetic cause of juvenile glaucoma
Peer-Reviewed Publication
Updates every hour. Last Updated: 7-May-2026 11:16 ET (7-May-2026 15:16 GMT/UTC)
A major international study led by Flinders University has identified a genetic contributor to juvenile glaucoma.
Published today in leading US journal JAMA Ophthalmology, the study marks another important step towards treating multiple forms of glaucoma with the support of genetic testing. While glaucoma typically affects older adults, many people are unaware it can affect younger people too.
A surprising breakthrough in anti-aging research raises hopes of delaying muscle aging and weakness by harnessing the potential of a garlic-derived compound, S-1-propenyl-L-cysteine (S1PC). Researchers identify a key role for S1PC in orchestrating a key inter-organ communication between fat tissue and the hypothalamus in the brain, thus supporting muscle function in aged mice. Elements of this signaling mechanism were also observed in humans, highlighting the potential of S1PC-based anti-aging interventions.
Transcranial magnetic stimulation (TMS) is a non-invasive, FDA-approved therapy that uses brief magnetic pulses to treat depression, particularly in patients who do not respond to medication. Yet scientists have long struggled to understand how it works at the level of brain cells and circuits.
A research paper by scientists from South China University of Technology designed a fabric-based ultrathin flexible microelectrode array with novel stimulation–inhibition electrode units that reduces current diffusion and improves focusing, improving tactile feedback accuracy and clarity.
The new research paper, published on Apr. 1 in the journal Cyborg and Bionic Systems, proposed a fabric-based microelectrode array (FMA) incorporating a stimulation–inhibition electrode unit structure, aiming to improve the precision of tactile perception, especially for applications in VR environments.